Supreme Court Leaves Mifepristone Access Unchanged – For Now Published: May 14, 2026

https://www.kff.org/quick-take/supreme-court-leaves-mifepristone-access-unchanged-for-now/?utm_campaign=KFF-This-Week&utm_medium=email&_hsenc=p2ANqtz-_WOiq9n9ms0SpxX5vSdUgLLs21vKHovujanea184bIajbeJTGFwtgxD8PtrUQfTyA0Bqsgw2Lzg4zzgd7nGfAEUh9U3Q&_hsmi=418967551&utm_content=418967551&utm_source=hs_email Yesterday, the Supreme Court ruled that blocked a lower court order in Louisiana v. FDA that would have restricted the nationwide distribution of mifepristone. The Court’s action leaves current FDA rules in place, allowing mifepristone – part of a two-drug regimen used in medication abortion – to be prescribed via telehealth and dispensed by mail or at retail pharmacies while the litigation continues pending a final decision by the Supreme Court. Justice Alito and Thomas dissented from the Court’s decision. The case now returns to the 5th Circuit Court of Appeals for further consideration.